1.
Impact of European medicines agency regulatory action for hydroxyzine initiation in people with contraindications in Scotland, England, Denmark and the Netherlands: An interrupted...
2.
3.
4.
Impact of European medicines agency regulatory action on hydroxyzine initiation, discontinuation and switching to other medicines in Scotland, England, Denmark and the Netherlands:...